Breast ultrasound examination and needle aspirate sample
With an ultrasound examination it is possible to find out more about the nature of the change in the breast. Ultrasound is harmless and effortless for the patient.
If you find a lump in your breast, we recommend mammography and an ultrasound as the primary tests. If necessary, we also take a needle aspirate sample, and if the results show anything indicative of cancer, we start investigating the tumor staging and size with tests such as MRI scan.
A real-time ultrasound also helps us guide the needle when taking a needle aspirate sample. A needle aspirate sample, in other words a biopsy, is usually taken if previous test results have contained anything suspicious. Based on the tissue sample from the biopsy, the pathologist determines the type of breast cancer and the differentiation rate as well as other factors important for treatment, if necessary. The pathologist’s results take a few weekdays to arrive.
Your safety is the most important to us
Many cancer patients have several concerns when it comes to the coronavirus pandemic, e.g. how does the situation impact my...Read more
Cancer and Coronavirus – FAQ
The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.Read more
Genuinely personalised cancer treatment – What does it mean?
Genuinely personalised cancer treatment is based on genetics and individual needs. At Docrates Cancer Center, treatment is supervised by Chief...Read more
Latest scientific information in oncology
The physicians of Docrates Cancer Center took part in a major event organised by the American Society of Clinical Oncology...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay even during epidemic.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.